DK175344B1 - Peptider med bradykininantagonistisk virkning og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse samt farmaceutiske midler indeholdende peptiderne - Google Patents

Peptider med bradykininantagonistisk virkning og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse samt farmaceutiske midler indeholdende peptiderne Download PDF

Info

Publication number
DK175344B1
DK175344B1 DK198903840A DK384089A DK175344B1 DK 175344 B1 DK175344 B1 DK 175344B1 DK 198903840 A DK198903840 A DK 198903840A DK 384089 A DK384089 A DK 384089A DK 175344 B1 DK175344 B1 DK 175344B1
Authority
DK
Denmark
Prior art keywords
arg
pro
gly
tic
ser
Prior art date
Application number
DK198903840A
Other languages
Danish (da)
English (en)
Other versions
DK384089D0 (da
DK384089A (da
Inventor
Bernward Schoelkens
Gerhard Breipohl
Jochen Knolle
Hans-Wolfram Fehlhaber
Hiristo Anagnostopulos
Stephan Henke
Jens Stechl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK384089D0 publication Critical patent/DK384089D0/da
Publication of DK384089A publication Critical patent/DK384089A/da
Application granted granted Critical
Publication of DK175344B1 publication Critical patent/DK175344B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK198903840A 1988-11-24 1989-08-04 Peptider med bradykininantagonistisk virkning og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse samt farmaceutiske midler indeholdende peptiderne DK175344B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3839581 1988-11-24
DE3839581 1988-11-24
DE3916291 1989-05-19
DE3916291 1989-05-19
DE3918225 1989-06-03
DE3918225 1989-06-03

Publications (3)

Publication Number Publication Date
DK384089D0 DK384089D0 (da) 1989-08-04
DK384089A DK384089A (da) 1990-05-25
DK175344B1 true DK175344B1 (da) 2004-08-30

Family

ID=27198531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198903840A DK175344B1 (da) 1988-11-24 1989-08-04 Peptider med bradykininantagonistisk virkning og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse samt farmaceutiske midler indeholdende peptiderne

Country Status (26)

Country Link
EP (1) EP0370453B1 (no)
JP (1) JPH07121956B2 (no)
KR (1) KR0139632B1 (no)
CN (1) CN1035006C (no)
AT (1) ATE107318T1 (no)
AU (1) AU612054B2 (no)
CA (1) CA1340667C (no)
CY (2) CY2028A (no)
CZ (1) CZ282384B6 (no)
DE (3) DE122008000066I2 (no)
DK (1) DK175344B1 (no)
ES (1) ES2057071T3 (no)
FI (1) FI94353C (no)
HK (1) HK1006716A1 (no)
HU (2) HU210566B (no)
IE (1) IE63490B1 (no)
IL (1) IL91298A (no)
LU (1) LU91499I2 (no)
LV (1) LV10720B (no)
MX (1) MX9203277A (no)
NL (1) NL300359I2 (no)
NO (2) NO177597C (no)
NZ (1) NZ230244A (no)
PH (1) PH31009A (no)
PT (1) PT91692B (no)
SK (1) SK279315B6 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
US5648333A (en) * 1988-11-24 1997-07-15 Hoechst Aktiengesellschaft Peptides having bradykinin antagonist action
EP0502987B1 (en) * 1989-12-08 1994-08-31 Trustees Of Boston University Acylated bradykinin antagonists and uses therefor
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
US5416191A (en) * 1991-04-01 1995-05-16 Cortech, Inc. Bradykinin antagonists
US5843900A (en) * 1991-04-01 1998-12-01 Cortech, Inc. Bradykinin antagonists
US6770741B1 (en) 1991-04-19 2004-08-03 Scios Inc. Bradykinin antagonist peptides
CA2106762C (en) * 1991-04-19 2000-10-10 Donald J. Kyle Bradykinin antagonist peptides
EP0618809B1 (en) * 1991-04-19 1998-08-19 Scios Nova Inc. Bradykinin type peptides
HUT63060A (en) * 1991-08-22 1993-07-28 Hoechst Ag Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
TW199863B (no) * 1991-12-21 1993-02-11 Hoechst Ag
WO1993017701A1 (en) * 1992-03-12 1993-09-16 The Administrators Of The Tulane Educational Fund Endothelin receptor-binding peptides
TW258739B (no) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5610142A (en) * 1992-10-08 1997-03-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
US5686565A (en) * 1992-10-08 1997-11-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
US5541286A (en) * 1992-10-08 1996-07-30 Scios Nova Inc. Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
US5817756A (en) * 1993-09-09 1998-10-06 Scios Inc. Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
CA2184824A1 (en) * 1994-03-09 1995-09-14 Val S. Goodfellow Bradykinin antagonist peptides incorporating n-substituted glycines
IL109943A (en) 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US6407059B1 (en) 1994-06-08 2002-06-18 Peptor Limited Conformationally constrained backbone cyclized peptide analogs
AU6044496A (en) * 1995-06-05 1996-12-24 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opi oid agonistic activity
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6051554A (en) * 1995-06-07 2000-04-18 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
US5849863A (en) * 1995-09-08 1998-12-15 University Of Colorado Cytolytic bradykinin antagonists
US5834431A (en) * 1995-09-08 1998-11-10 Cortech, Inc. Des-Arg9 -BK antagonists
FR2739553B1 (fr) 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6841533B1 (en) 1995-12-07 2005-01-11 Peptor Limited Conformationally constrained backbone cyclized interleukin-6 antagonists
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
DE19642289A1 (de) 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
DE10304994A1 (de) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
CN102532267B (zh) * 2012-02-09 2014-06-18 深圳翰宇药业股份有限公司 一种艾替班特的制备方法
CN104043101B (zh) * 2014-05-23 2016-04-20 杭州阿德莱诺泰制药技术有限公司 一种艾替班特注射用组合物及其制备方法和制剂
KR102099509B1 (ko) 2018-07-27 2020-04-09 강경순 과수용 받침지주
CN111944016B (zh) * 2020-08-25 2022-04-29 台州吉诺生物科技有限公司 一种醋酸艾替班特的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3044236A1 (de) * 1980-11-25 1982-06-16 Hoechst Ag, 6000 Frankfurt Aminosaeurederivate und verfahren zu ihrer herstellung
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3227055A1 (de) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung
FR2575753B1 (fr) * 1985-01-07 1987-02-20 Adir Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides

Also Published As

Publication number Publication date
CY2008022I2 (el) 2009-11-04
FI94353B (fi) 1995-05-15
NL300359I1 (nl) 2008-11-03
DE122008000066I2 (de) 2009-11-05
CY2008022I1 (el) 2009-11-04
PH31009A (en) 1997-12-23
MX9203277A (es) 1992-07-01
EP0370453B1 (de) 1994-06-15
ES2057071T3 (es) 1994-10-16
FI94353C (fi) 1995-08-25
CN1042918A (zh) 1990-06-13
EP0370453A2 (de) 1990-05-30
HK1006716A1 (en) 1999-03-12
NL300359I2 (nl) 2009-02-02
DE122008000066I1 (de) 2009-05-20
IE63490B1 (en) 1995-05-03
CY2028A (en) 1998-02-20
PT91692B (pt) 1995-05-31
PT91692A (pt) 1990-03-30
CN1035006C (zh) 1997-05-28
NO2008016I1 (no) 2008-11-17
SK490689A3 (en) 1998-09-09
CA1340667C (en) 1999-07-20
NO177597B (no) 1995-07-10
KR0139632B1 (ko) 1998-07-01
HUT52527A (en) 1990-07-28
CZ490689A3 (en) 1997-03-12
ATE107318T1 (de) 1994-07-15
NO2008016I2 (no) 2012-10-01
IL91298A (en) 1994-05-30
NZ230244A (en) 1992-06-25
AU3943189A (en) 1990-05-31
DE3938751A1 (de) 1990-05-31
JPH07121956B2 (ja) 1995-12-25
NO893193D0 (no) 1989-08-08
FI893738A0 (fi) 1989-08-08
EP0370453A3 (de) 1991-12-04
NO893193L (no) 1990-05-25
LV10720B (en) 1996-02-20
IL91298A0 (en) 1990-03-19
IE892522L (en) 1990-05-24
HU210566B (en) 1995-05-29
CZ282384B6 (cs) 1997-07-16
AU612054B2 (en) 1991-06-27
SK279315B6 (sk) 1998-09-09
DE58907889D1 (de) 1994-07-21
FI893738A (fi) 1990-05-25
DK384089D0 (da) 1989-08-04
KR900007870A (ko) 1990-06-02
LU91499I2 (fr) 2009-01-19
JPH02184697A (ja) 1990-07-19
NO177597C (no) 1995-10-18
HU210712A9 (en) 1995-06-28
DK384089A (da) 1990-05-25
LV10720A (lv) 1995-06-20

Similar Documents

Publication Publication Date Title
DK175344B1 (da) Peptider med bradykininantagonistisk virkning og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse samt farmaceutiske midler indeholdende peptiderne
KR0173976B1 (ko) 브라디키닌에 대하여 길항작용을 하는 펩타이드
US5648333A (en) Peptides having bradykinin antagonist action
JP3426639B2 (ja) Ｎ−末端に修飾を有するペプチド
FI109541B (fi) Menetelmä bradykiniiniantagonistien valmistamiseksi
RU2083586C1 (ru) Пептиды или их физиологически приемлемые соли
LT3872B (en) Novel peptides and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2008 00052

Filing date: 20081218

Expiry date: 20140804

PUP Patent expired
CTFG Supplementary protection certificate (spc) issued

Free format text: PRODUCT NAME: ICATIBANT OG FARMACEUTISK ACCEPTABLE SALTE HERAF, HERUNDER ICATIBANT ACETAT

Spc suppl protection certif: CA 2008 00052

Filing date: 20081218